Denali Therapeutics DNLI
NASDAQ DNLI
$20.00 -0.53 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Price to Earnings (2020 - 2021)

Updated

Denali Therapeutics' (DNLI) Price to Earnings stood at 208.20 in Q3 2021, up 22.1% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Price to Earnings (2020 - 2021) Analysis & Trends

For FY2020, Denali Therapeutics' Price to Earnings came in at 141.92.

  • Per Business Quant, the preceding three quarters came in at 170.46 (Q2 2021), 119.56 (Q1 2021) and 141.92 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Denali Therapeutics 3.28 Bn 3.28 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 208.20
Jun 30, 2021 170.46
Mar 31, 2021 119.56
Dec 31, 2020 141.92
API Access

Denali Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=DNLI&period=max&api_key=YOUR_API_KEY